Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia
HAEMATOLOGICA
Racil, Z; Razga, F; Drapalova, J; Buresova, L; Zackova, D; Palackova, M; Semerad, L; Malaskova, L; Haluzik, M; Mayer, J, 2013: Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia. HAEMATOLOGICA 98(10), doi: 10.3324/haematol.2013.086355
CEITEC authors: